Effects of In Vitro Synergism of Eunkyo-san and Rufloxacin against 9 Strains of Aerobic Gram(+) Bacteria |
Shin Ho Pill
(Division of Respiratory System, College of Oriental Medicine, Daegu Haany University)
Jeon Kwi Ok (Division of Respiratory System, College of Oriental Medicine, Daegu Haany University) Park Mee Yeon (Division of Respiratory System, College of Oriental Medicine, Daegu Haany University) Kim Dae Jun (Division of Respiratory System, College of Oriental Medicine, Daegu Haany University) Choi Hae Yun (Division of Respiratory System, College of Oriental Medicine, Daegu Haany University) Kim Jong Dae (Division of Respiratory System, College of Oriental Medicine, Daegu Haany University) |
1 |
In vitro short-term and long-term cytotoxicity of fluoroquinolones on murine cell lines
/
|
2 |
/
|
3 |
Clinical use of the quinolones
/
|
4 |
Antibiotic resistance
/
|
5 |
Single or double mutation alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli
/
ScienceOn |
6 |
A sequence variant of Staphylococcus hominis with a high prevalence of oxacillin and fluoroquinolone resistance
/
|
7 |
Reduced fluoroquinolone susceptibility in Salmonella enterica serotypes in travelers returning from southeast Asia
/
|
8 |
New mutation in parE in a pneumococcal in vitro mutant resistant to fluoroquinolones
/
|
9 |
Characterization of sparfloxacin-resistant mutants of Staphylococcus aureus obtained in vitro
/
|
10 |
Fluoroquinolone resistance among clinical isolates of Streptococcus pneumoniae belonging to international multiresistant clones
/
|
11 |
麻黃潤肺湯이 ovalbumin으로 誘發된 mouse의 喘息에 미치는 影響
/
|
12 |
麻黃潤肺湯과 rufloxacin 倂用이 Gram(+) 細菌柱에 대한 試驗管內 抗菌力에 미치는 影響
/
|
13 |
麻黃潤肺湯과 ciproxacin 倂用이 Gram(+) 細菌柱에 대한 試驗管內 抗菌力에 미치는 影響
/
|
14 |
A new tricyclic fluoroquinolone, rufloxacin(MF-934), with interesting antibacterial and pharmacokinetic characteristics
/
|
15 |
In vitro activity of a new quinolone, rufloxacin, against nosocomial isolates
/
|
16 |
Fluoroquinolones: utilization in renal and urogenital tract infections
/
|
17 |
/
|
18 |
/
|
19 |
Quinolone generations: natural history or natural selection?
/
|
20 |
Is more than one quinolone needed in clinical practice?
/
|
21 |
Mode of action of fluoroquinolones
/
|
22 |
Mechanisms of action of antimicrobials: focus on fluoroquinolones
/
|
23 |
History of quinolones and their side effects
/
|
24 |
Toxicity of quinolones
/
|
25 |
Rufloxacin(MF-934): in vitro and in vivo antibacterial activity
/
|